Journals / Erciyes Medical Journal / 2019 / Cilt: 41 - Sayı: 4

The Fusion of T2 Weighted MRI and Diffusion-Weighted Imaging in Evaluating the Depth of Myometrial Invasion in Endometrial Cancer

Pages
375–380
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It can be used as an alternative diagnostic tool for endometrial carcinoma staging with reduced cost and injection of a contrast agent.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the performance of fused T2WI-diffusion-weighted imaging (DWI) in the preoperative evaluation of the depth of myometrial invasion in endometrial cancer.
📊
Key Findings & Data:All of them underwent a full magnetic resonance imaging exam including T2-weighted images and DWI with b values of 0, 500, and 1000 s/mm2.
💡
Conclusion & Impact:It can be used as an alternative diagnostic tool for endometrial carcinoma staging with reduced cost and injection of a contrast agent.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: To investigate the performance of fused T2WI-diffusion-weighted imaging (DWI) in the preoperative evaluation of the depth of myometrial invasion in endometrial cancer. Materials and Methods: Twenty-nine patients with histologically proven endometrial carcinoma were enrolled in this study. All of them underwent a full magnetic resonance imaging exam including T2-weighted images and DWI with b values of 0, 500, and 1000 s/mm2. The ADC value in endometrial cancer and normal endometrium of control cases was calculated. The myometrial invasion depth was judged in each sequence separately as well as by fused images, and was correlated with the surgical pathology results. Results: In the evaluation of superficial myometrial invading lesions using the fused T2WI-DWI, the sensitivity was found to be 94.7%, specificity was 90%, and accuracy was 94.7%, while the values of about 90% sensitivity, 94.9% specificity, and 90% accuracy of fused T2WI-DWI in the evaluation of deep myometrial invading lesions were obtained. On the ADC maps, the mean ADC value of endometrial cancer was 0.9±0.17×10−3 mm2/s and the mean ADC value of normal endometrium of control cases was 1±0.11×10−3 mm2/s. Conclusion: The fusion of T2WI and DWI showed a good noninvasive diagnostic method of staging of invasion and preoperative depth. It can be used as an alternative diagnostic tool for endometrial carcinoma staging with reduced cost and injection of a contrast agent.

🔖

Cite This Article

SHATAT, O. M. M., FAKHRY, S., HELAL, M. H. (2019). The Fusion of T2 Weighted MRI and Diffusion-Weighted Imaging in Evaluating the Depth of Myometrial Invasion in Endometrial Cancer. Erciyes Medical Journal, Cilt: 41 - Sayı: 4, 375–380. https://ajindex.com/articles/218294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CACancer J Clin 2018; 68(6): 394–24
  2. Rockall AG, Qureshi M, Papadopoulou I, Saso S, Butterfield N, Thomassin-Naggara I, et al. Role of imaging in fertility-sparing treatment of gynecologic malignancies. Radiographics 2016; 36(7): 2214–33
  3. Zhang H, Cui J, Jia L, Hong S, Kong B, Li D. Comparison of laparoscopy and laparotomy for endometrial cancer. Int J Gynecology Obstet 2012; 116(3): 185–91
  4. Hahn HS, Yoon SG, Hong JS, Hong SR, Park SJ, Lim JY, Kwon YS, Lee IH, Lim KT, Lee KH, Shim JU. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer 2009; 19(6): 1068–73
  5. Aloisi A, Plotti F, Scaletta G, Capriglione S, Laraud F, Miranda A, et al. Chemotherapy as Adjuvant Treatment for Intermediate-High Risk Early-Stage Endometrial Cancer: A Pilot Study. Int J Gynecol Cancer 2015; 25(8): 1418–23
  6. Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB, et al. Endometrial cancer: a review and current management strategies: part II. Gynecol Oncol 2014; 134(2): 393–402
  7. Guo Y, Wang P, Wang P, Gao W, Li F, Yang X, et al. Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusionweighted magnetic resonance imaging. OncoTargets Ther 2017; 10: 5937–43
  8. Capriglione S, Plotti F, Miranda A, Lopez S, Scaletta G, Moncelli M, et al. Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4. Expert Rev Anticancer Ther 2017; 17(1): 9–18
  9. Haldorsen IS, Salvesen HB. Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. Clinical Radiol 2012; 67(1): 2–12
  10. Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, et al. Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. BMC Cancer 2012; 12: 128
  11. Panici PB, Basile S, Maneschi F, Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 2008; 100(23): 1707–16
  12. Dhanda S, Thakur M, Kerkar R, Jagmohan P. Diffusion-weighted imaging of gynecologic tumors: diagnostic pearls and potential pitfalls. Radiographics 2014; 34(5):